Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“MedCity news is a peerless national resource for those of us who really want to stay on top the very latest news in healthcare from incumbents to startups. ”

Elliot Menschik, DreamIt Ventures partner; Venturef0rth founder; Penn professor


Sign up for our daily newsletter


Acuity Medical raises $1.5M for macular degeneration device

12:16 pm by | 0 Comments

Acuity Medical Systems Inc. has raised $1.5 million from the sale of equity, according to documents filed with the Securities and Exchange Commission.

Overall, the Minneapolis-based startup is seeking $2.9 million, the documents say.

Acuity is developing neurostimulation technology to treat dry macular degeneration, a chronic eye disease that primarily affects older patients, causing blurred vision and even blindness in central vision.

There are two types of macular degeneration — wet and dry. The former is caused by swelling from leaky blood vessels in the  back of the eye. The latter concerns the deterioration of macula — the layer of tissue on the inside back wall of the eyeball that forms the center of the retina.

Advertisement

By shooting low levels of electricity into the retina, Acuitive says its device can restore the normal balance of blood and oxygen flow in the area, and proper disposal of metabolic waste.

Founded in 1998, Acuity is led by CEO Blair Mowery, a top executive with The M&A Group, an investment bank in Minneapolis.

Acuity is not the only Minnesota startup exploring this technology. ScyFIX Inc., based in Chanhassen, Minnesota, also is working on neurostimulation therapies to treat a range of degenerative eye diseases, including macular degeneration, glaucoma and retinitis.

Enhanced by Zemanta

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Thomas Lee

By Thomas Lee

Thomas Lee was the Minnesota Bureau Chief for MedCityNews.
More posts by Author

0 comments

Hear the latest news first

Get our daily newsletter or follow us.

 

Advertisement